John A Hartley Selected Research

John A Hartley Research Topics

Disease

62	Neoplasms (Cancer) 02/2024 - 07/2003
7	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 03/2004
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 06/2015
5	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 04/2011
5	Leukemia 01/2018 - 06/2003
4	Lymphoma (Lymphomas) 02/2024 - 11/2016
4	Melanoma (Melanoma, Malignant) 08/2015 - 09/2004
4	Breast Neoplasms (Breast Cancer) 12/2013 - 09/2004
3	Adenocarcinoma 02/2024 - 12/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 10/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 06/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 04/2006
2	Hypoxia (Hypoxemia) 02/2018 - 11/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 08/2005
2	Glioma (Gliomas) 07/2014 - 09/2004
2	Multiple Myeloma 09/2012 - 07/2002
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Residual Neoplasm 10/2021
1	Cytokine Release Syndrome 10/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Liver Neoplasms (Liver Cancer) 10/2019
1	Autoimmune Diseases (Autoimmune Disease) 10/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2016
1	Circulating Neoplastic Cells 01/2016
1	Disease Progression 01/2016

Drug/Important Bio-Agent (IBA)

32	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 07/2002
12	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 11/2015
9	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 07/2023 - 11/2016
9	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2004
5	ProdrugsIBA 10/2019 - 11/2004
5	ErbB Receptors (EGF Receptor)IBA 06/2016 - 10/2004
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2015
4	1,1'- ((propane- 1,3- diyl)dioxy)bis(7- methoxy- 2- methylidene- 1,2,3,10,11,11a- hexahydro- 5H- pyrrolo(2,1- c)(1,4)benzodiazepin- 5,11- dione)IBA 06/2011 - 09/2004
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 04/2015
3	Proteins (Proteins, Gene)FDA Link 03/2015 - 09/2004
3	Gefitinib (Iressa)FDA Link 12/2013 - 10/2004
3	Melphalan (Alkeran)FDA LinkGeneric 09/2012 - 07/2002
3	Etoposide (VP 16)FDA LinkGeneric 11/2009 - 10/2004
2	Peptides (Polypeptides)IBA 02/2024 - 01/2020
2	Cytotoxins (Cytolysins)IBA 02/2024 - 11/2004
2	loncastuximab tesirineIBA 01/2023 - 01/2018
2	olaparibIBA 01/2022 - 02/2018
2	vandetanib (ZD6474)IBA 01/2022 - 10/2019
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2021 - 03/2015
2	N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA 02/2018 - 12/2015
2	A-factor (Streptomyces)IBA 10/2017 - 07/2010
2	Trastuzumab (Herceptin)FDA Link 01/2017 - 11/2009
2	Gemcitabine FDA Link 12/2015 - 10/2010
2	PoisonsIBA 12/2013 - 09/2004
2	PlatinumIBA 09/2012 - 10/2010
2	Drug CombinationsIBA 06/2011 - 07/2010
2	Nylons (Nylon)IBA 05/2010 - 01/2007
2	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2007 - 11/2004
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 02/2024
1	IminesIBA 01/2023
1	AZD 8931IBA 01/2023
1	monomethyl auristatin EIBA 01/2022
1	auristatinIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 11/2021
1	ParaffinIBA 11/2021
1	Chimeric Antigen ReceptorsIBA 10/2021
1	SteroidsIBA 10/2021
1	LigandsIBA 09/2021
1	futuximabIBA 01/2020
1	Cell Surface ReceptorsIBA 01/2020
1	IntegrinsIBA 01/2020
1	GlucuronidaseIBA 10/2019
1	Histones (Histone)IBA 10/2018
1	glutamate carboxypeptidaseIBA 10/2018
1	MEDI3726IBA 10/2018
1	AntigensIBA 10/2018
1	Adenosine Diphosphate (ADP)IBA 02/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2018
1	TH 302IBA 02/2018
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 02/2018
1	CD19 AntigensIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Tubulin ModulatorsIBA 01/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2018
1	Interleukin-2 (IL2)IBA 10/2017
1	ChromatinIBA 01/2017
1	rovalpituzumab tesirineIBA 11/2016
1	Cetuximab (Erbitux)FDA Link 06/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2016
1	ElementsIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2015
1	NucleosidesIBA 12/2015
1	Caspase 3 (Caspase-3)IBA 12/2015

Therapy/Procedure

21	Therapeutics 02/2024 - 10/2004
8	Drug Therapy (Chemotherapy) 01/2023 - 09/2004
2	Stem Cell Transplantation 10/2021 - 07/2002
1	Aftercare (After-Treatment) 01/2022
1	Castration 10/2018
1	Immunotherapy 10/2017
1	Adjuvant Chemotherapy 01/2017